Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study-Reference-Cited by-同舟云学术

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study

Published:2019-08-31 Issue:3 Volume:17 Page:423-431
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Woo Young Sup¹,Yoon Bo-Hyun²^ORCID,Jeon Bong-Hee²,Seo Jeong Seok³,Nam Beomwoo³,Lee Sang-Yeol⁴,Jae Young-Myo⁵,Jang Sae-Heon⁵,Eun Hun Jeong⁶,Won Seung-Hee⁷,Lee Kwanghun⁸,Lee Jonghun⁹,Bahk Won-Myong¹^ORCID

Affiliation:

1. Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea

2. Department of Psychiatry, Naju National Hospital, Naju, Korea

3. Department of Psychiatry, School of Medicine, Konkuk University, Chungju, Korea

4. Department of Psychiatry, Wonkwang University School of Medicine, Iksan, Korea

5. Department of Psychiatry, Bongseng Memorial Hospital, Busan, Korea

6. Department of Neuropsychiatry, Presbyterian Medical Center-Jesus Hospital, Jeonju, Korea

7. Department of Psychiatry, School of Medicine, Kyungpook National University, Daegu, Korea

8. Department of Psychiatry, College of Medicine, Dongguk University, Gyeongju, Korea

9. Department of Psychiatry, School of Medicine, Catholic University of Daegu, Daegu, Korea

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2019/017/cpn017-03-10.pdf

Reference40 articles.

1. The Longitudinal Course of Schizophrenia Across the Lifespan

2. Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation Strategies

3. The NIMH-MATRICS Consensus Statement on Negative Symptoms

4. Remission criteria for schizophrenia: Evaluation in a large naturalistic cohort

5. Guidelines for the Pharmacotherapy of Schizophrenia in Adults

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials;BMC Psychiatry;2023-10-11

2. Safety and effectiveness of oral blonanserin for schizophrenia in adolescents in China: Data from a 12-week post-marketing surveillance;The European Journal of Psychiatry;2023-10

3. Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics;Psychiatry Research;2023-04

4. Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance;BMC Psychiatry;2023-02-21

5. Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance;Frontiers in Psychiatry;2022-08-18